918博天堂(中华区)官方网站

A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects

Original Research Article：

Frontiers in Pharmacology

http:// 10.3389/fphar.2021.646171